India's Biocon targets developed markets with biosimilars; EU ban to cost Indian industry $1.2B;

@FiercePharma: Harvard scientists link pesticides with bee losses. More from FierceAnimalHealth | Follow @FiercePharma

@EricPFierce: Lupin lands its first US manufacturing site with $880M deal for GAVIS, 6-year-old NJ firm. FiercePharmaManufacturing story | Follow @EricPFierce

@CarlyHFierce: ICYMI Friday: UnitedHealth uses newfound scale to negotiate pay-for-performance deals. Article | Follow @CarlyHFierce

> India's Biocon said it expects to be introducing biosimilars into developed markets over the next three years as patents fall off. Story

> An EU ban on 700 generic drugs from India for which there were questions about how GVK Biosciences handled trials will cost the Indian industry an estimated $1.2 billion. Story

> Sun Pharmaceutical is expected to raise $1 billion with a bond sale after paying completing its $4 billion deal for Ranbaxy Laboratories. Report

> UK-based consumer health company Reckitt Benckiser today raised its full-year earnings forecast, saying it expects growth of 5%, helped in part by cold med Mucinex. Story

Medical Device News

@FierceMedDev: ICYMI: Oxford Performance Materials gets FDA nod for 3-D printed spinal implant. Report | Follow @FierceMedDev

@EmilyWFierce: ICYMI from FiercePharma: Shire CEO: We're prepared to wait for the right deal. Article | Follow @EmilyWFierce

> Varian signs $124M deal with U.K.'s NHS for ProBeam cancer therapy. News

> Sorin stock plummets as Italian feds seek to block its merger with Cyberonics. Story

> Docs dole out recs for reducing fetal ultrasound procedures in the U.S. More

Biotech News

@FierceBiotech: Allergan bags NMDA depression drugs in $560M-plus Naurex buyout. News | Follow @FierceBiotech

@JohnCFierce: The China stock landslide is back on. More from Reuters | Follow @JohnCFierce

@DamianFierce: I kinda forgot this hadn't already happened, tbh. Aegerion release/Article | Follow @DamianFierce

> Nymox soars after claims of a post-PhIII BPH turnaround. News

> Eli Lilly soldiers on in big PhIII evacetrapib study. Item

> Allergan joins the hunt for a 'transformational' biotech deal. Editor's corner

Animal Health News

> Animal health drives double-digit growth at Abaxis. Report

> Harvard scientists link pesticides with bee losses. Item

> H.J. Baker breaks ground on multimillion-dollar facility near KC animal health corridor. More

> USDA speeds development of bird flu vaccine as fears of revived virus mount. Article

> Aratana predicts full launch of two lymphoma drugs for dogs in late 2016. Story

Biotech IT News

> SynBio startup Ginkgo Bioworks lands $45M to fuel push into pharma. More

> PCORI board signs off on $142.5M investment to scale up health data network. Story

> BGI CEO steps down to escalate interest in artificial intelligence. Article

> Deep Genomics sets up shop to marry deep learning and genomics. Item

> Oxford Nanopore raises $109M ahead of key period for its sequencing technology. Report

Pharma Marketing News

> Sanofi draws a $14,600 line in the sand for Praluent payer fight. Report

> Spotlight-savvy Kim Kardashian adds Duchesnay med to her talking points. Story

> Will marketing make the difference in approval of Sprout's 'pink pill' for women? News

> J&J's Stelara may be under fire in psoriasis, but it's positioned to score elsewhere. More

> I'll prescribe it if you do: Prescribers susceptible to peer pressure, study finds. Report